References
Jannin A, Lamartina L, Moutarde C, Djennaoui M, Lion G, Chevalier B, Vantyghem MC, Deschamps F, Hadoux J, Baudin E, Schlumberger M, Leboulleux S, Do Cao C. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur J Nucl Med Mol Imaging. 2022;49(7):2401–13. https://doi.org/10.1007/s00259-022-05697-w.
World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Colombia fact sheets. [homepage on the internet]; 2020 [cited 2022 March 28]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf.
Chung J-K, Cheon GJ. Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. Endocrinol Metab. 2014;29:233. https://doi.org/10.3803/enm.2014.29.3.233.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Letter to the Editor
Rights and permissions
About this article
Cite this article
Veloza Vega, M.J., Gallo, M., Ucros, G. et al. Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”. Eur J Nucl Med Mol Imaging 49, 3622–3623 (2022). https://doi.org/10.1007/s00259-022-05869-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-022-05869-8